Patent Application
Provisional
Small
App. No. 60/623,342
· Confirmation No. 7896
Remodeling and glycopegylation of fibroblast growth factor (FGF)
Inventor:
Shawn DeFrees
Provisional Application Expired
Inventors
Shawn DeFrees
North Wales, PA
Attorneys & Agents of Record
Prosecution
- Customer No.
- 43850
- Docket No.
- 040853-01-5163PR
- Confirmation No.
- 7896
Child
Claims priority from a provisional application
→
App. 13/332,708
· US 9,200,049
Filed 2011-12-21
· Patented Case
Child
Claims priority from a provisional application
→
App. 14/954,696
· US 10,874,714
Filed 2015-11-30
· Patented Case
Child
Claims priority from a provisional application
→
App. 11/665,908
Filed 2007-11-26
· Abandoned -- Failure to Respond to an Office Action
Child
PCT
Claims priority from a provisional application
→
PCT/US2005/039226
Filed 2005-10-31
· PCT - IPER (International Preliminary Examination Report) 409-416 Mailed
Child
Claims priority from a provisional application
→
App. 17/075,011
Filed 2020-10-20
· Abandoned -- Failure to Respond to an Office Action
from
RATIOPHARM GMBH,
TEVA BRANDED PHARMACEUTICAL PRODUCTS R&D, INC.,
TEVA PHARMACEUTICAL INDUSTRIES LTD.
ASSIGNMENT OF ASSIGNOR'S INTEREST
Recorded 2019-10-24
from
RATIOPHARM GMBH,
TEVA BRANDED PHARMACEUTICAL PRODUCTS R&D, INC.,
TEVA PHARMACEUTICAL INDUSTRIES LTD.
CORRECTIVE ASSIGNMENT TO CORRECT THE APPLICATION NUMBER 62/623342 PREVIOUSLY RECORDED ON REEL 050112 FRAME 0408. ASSIGNOR(S) HEREBY CONFIRMS THE LICENSE ASSIGNMENT.
Recorded 2019-10-24
from
RATIOPHARM GMBH,
TEVA BRANDED PHARMACEUTICAL PRODUCTS R&D, INC.,
TEVA PHARMACEUTICAL INDUSTRIES LTD.
ASSIGNMENT OF ASSIGNOR'S INTEREST
Recorded 2019-08-21
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this application's details
Quick Facts
- App. No.
- 60/623,342
- Filed
- 2004-10-29
External Links